Insider holders · CIK 0001510580
Kite Pharma, Inc. · KITE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Steven B RuchefskyDirector | 0 | 946,420 | 946,420 | Oct 5, 2017 · 8:21 pm EDT | Form 4 |
| Margo R RobertsChief Scientific Officer | 10,655 | — | 10,655 | Mar 17, 2016 · 9:14 pm EDT | Form 4 |
| Rizwana F SprouleVP Regulatory Affairs | 10,211 | — | 10,211 | Mar 17, 2016 · 9:15 pm EDT | Form 4 |
| Marc BetterVP, Product Sciences | 7,688 | — | 7,688 | Feb 3, 2016 · 7:04 pm EST | Form 4 |
| Owen N. WitteDirector | 0 | — | 0 | Oct 5, 2017 · 8:19 pm EDT | Form 4 |
| Paul L JenkinsonChief Financial Officer | 0 | 0 | 0 | Oct 5, 2017 · 8:13 pm EDT | Form 4 |
| Timothy L. MooreEVP, Technical Operations | 0 | — | 0 | Oct 5, 2017 · 8:17 pm EDT | Form 4 |
| Shawn TomaselloChief Commercial Officer | 0 | — | 0 | Oct 5, 2017 · 8:16 pm EDT | Form 4 |
| David D ChangEVP, R&D, Chief Medical Off. | 0 | — | 0 | Oct 5, 2017 · 8:12 pm EDT | Form 4 |
| Jeffrey WiezorekSVP Clinical Development | 0 | — | 0 | Oct 5, 2017 · 8:15 pm EDT | Form 4 |
| Ran NussbaumDirector | 0 | 0 | 0 | Oct 5, 2017 · 8:26 pm EDT | Form 4 |
| Franz B HumerDirector | 0 | — | 0 | Oct 5, 2017 · 8:24 pm EDT | Form 4 |
| Jonathan M PeacockDirector | 0 | — | 0 | Oct 5, 2017 · 8:28 pm EDT | Form 4 |
| Helen Susan KimEVP, Business Development | 0 | — | 0 | Oct 5, 2017 · 8:14 pm EDT | Form 4 |
| Ian T ClarkDirector | 0 | — | 0 | Oct 5, 2017 · 8:27 pm EDT | Form 4 |
| Arie BelldegrunChairman, President and CEO | 0 | 0 | 0 | Oct 5, 2017 · 8:10 pm EDT | Form 4 |
| Roy DoumaniDirector | 0 | 0 | 0 | Oct 5, 2017 · 8:23 pm EDT | Form 4 |
| Cynthia M ButittaChief Operating Officer | 0 | — | 0 | Oct 5, 2017 · 8:11 pm EDT | Form 4 |
| Joshua A KazamDirector | 0 | 0 | 0 | Oct 5, 2017 · 8:25 pm EDT | Form 4 |
| Farah ChampsiDirector | 0 | 0 | 0 | Oct 5, 2017 · 8:20 pm EDT | Form 4 |
| David BondermanDirector | 0 | 0 | 0 | Oct 5, 2017 · 8:22 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.